| PESUA14 | Administration of the broadly neutralizing, CD4-binding site targeting antibody VRC07-523LS in dual- and triple-antibody combinations with 10-1074, PGT121, and/or PGDM1400: impact on pharmacokinetics compared to VRC07-523LS administration alone | Poster exhibition | Humoral immunity (including broadly neutralizing antibodies), Antibodies and B cells |
| PESUA15 | Depot-medroxyprogeterone acetate use alters immune modulation function of cortisol and thyroid hormones | Poster exhibition | Mucosal immunity |
| PESUA16 | Role of the polgene enhancer in HIV-1 transcription and replication in myeloid infected cells | Poster exhibition | Host cellular factors and viral mechanisms of HIV/SIV persistence and latency |
| PESUA17 | Role of UHRF1 in HIV-1 transcriptional regulation | Poster exhibition | Host cellular factors and viral mechanisms of HIV/SIV persistence and latency |
| PESUA18 | In vivo and in vitro evidence for infection of naïve CD4 T cells with CCR5-tropic HIV | Poster exhibition | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
| PESUA19 | High prevalence of HIV persistence in CSF of adolescents and young adults with perinatally-acquired HIV and cognitive impairment in the IMPAACT 2015 study | Poster exhibition | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
| PESUA20 | Subtype A1 and D HIV-1 proviral genome landscape in Rakai, Uganda | Poster exhibition | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
| PESUA21 | The LRA HODHBt synergizes with IL-15 to enhance the cytotoxic capacity of HIV-specific CTL | Poster exhibition | Strategies to reduce/eliminate viral reservoirs |
| PESUA22 | Productively-infected CD4 T cells are resistant to ADCC mediated by non-neutralizing antibodies | Poster exhibition | Strategies to reduce/eliminate viral reservoirs |
| PESUA23 | Longer intervals between SARS-CoV-2 infection and SpikeVax doses improve the neutralization of different variants of concern | Poster exhibition | Immune responses to SARS-Cov2 |